Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No
- PMID: 22796835
- DOI: 10.1378/chest.12-1087
Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No
Comment in
-
Management of recurrent malignant pleural effusions: an ever-recurring issue?Chest. 2012 Dec;142(6):1696. doi: 10.1378/chest.12-2038. Chest. 2012. PMID: 23208361 No abstract available.
Comment on
-
Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes.Chest. 2012 Jul;142(1):15-17. doi: 10.1378/chest.12-1085. Chest. 2012. PMID: 22796834 No abstract available.
Similar articles
-
Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes.Chest. 2012 Jul;142(1):15-17. doi: 10.1378/chest.12-1085. Chest. 2012. PMID: 22796834 No abstract available.
-
[Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Dec 18;40(6):600-2. Beijing Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 19088831 Chinese.
-
[The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].Zentralbl Chir. 2010 Feb;135(1):54-8. doi: 10.1055/s-0029-1224646. Epub 2009 Dec 22. Zentralbl Chir. 2010. PMID: 20029741 German.
-
Treatment of Malignant Pleural Effusions.Clin Chest Med. 2025 Jun;46(2):227-240. doi: 10.1016/j.ccm.2025.02.002. Clin Chest Med. 2025. PMID: 40484498 Review.
-
Pleurodesis.Semin Respir Crit Care Med. 2019 Jun;40(3):375-385. doi: 10.1055/s-0039-1693997. Epub 2019 Sep 16. Semin Respir Crit Care Med. 2019. PMID: 31525812 Review.
Cited by
-
The treatment of pleural carcinosis with malignant pleural effusion.Dtsch Arztebl Int. 2013 May;110(18):313-8. doi: 10.3238/arztebl.2013.0313. Dtsch Arztebl Int. 2013. PMID: 23720697 Free PMC article. Review.
-
Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.J Cardiothorac Surg. 2021 May 4;16(1):125. doi: 10.1186/s13019-021-01475-1. J Cardiothorac Surg. 2021. PMID: 33947423 Free PMC article. Review.
-
Pleural Disease Management: Manometry-guided Thoracentesis, Optimal Drainage Regimen of Indwelling Pleural Catheters, and Talc Poudrage versus Slurry for Malignant Pleural Effusion.Am J Respir Crit Care Med. 2020 Aug 1;202(3):448-450. doi: 10.1164/rccm.202003-0599RR. Am J Respir Crit Care Med. 2020. PMID: 32421351 Free PMC article. No abstract available.
-
Viscum pleurodesis is as effective as talc pleurodesis and tends to have less adverse effect.Support Care Cancer. 2020 Nov;28(11):5463-5467. doi: 10.1007/s00520-020-05405-0. Epub 2020 Mar 12. Support Care Cancer. 2020. PMID: 32166382 Free PMC article.
-
Current status of and progress in the treatment of malignant pleural effusion of lung cancer.Front Oncol. 2023 Jan 20;12:961440. doi: 10.3389/fonc.2022.961440. eCollection 2022. Front Oncol. 2023. PMID: 36818672 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources